Sign in
4

Changes in Ownership

Emergent BioSolutions Inc. Filed Acc 0001367644-22-000042

EVP, Chief Financial Officer gave up 818 shares (to pay taxes)

  • EVP, Chief Financial Officer acquired 48,333 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

LINDAHL RICHARD S · EVP, Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Grant or award : show line 1 in the form +31,417 69,375 D
2022-03-01 Grant or award : show line 2 in the form +16,916 86,291 D
2022-02-28 Shares withheld for taxes : show line 3 in the form −818 $39.64 $32,426 85,473 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Grant or award : show line 4 in the form Employee Stock Options (Right to Buy) +38,664 $41.38 $1,599,916 38,664 D
Loading xslF345X03/wf-form4_164626472010733.xml…